Skip to content
Riskpilot
← Back to search
Sign in
Get full access
VELIN-PHARMA A/S
A/S
Active
CVR 33026013
Kongevejen 66, 3480
Fredensborg
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 1971 · 55 years old
— employees
Monitor
Share
Denmark
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
VELIN-PHARMA A/S
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
Income statement
DKK thousands
Item
2021
2022
2023
2024
2025
Gross profit
150
440
161
-3
95
Staff expenses
-0
-0
-0
-0
-0
EBITDA
150
440
161
-3
95
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
150
440
161
-3
95
Net financials
7.483
3.556
7.112
16.280
-16.041
Profit before tax
7.633
3.996
7.273
16.276
-15.946
Tax
1.679
879
1.726
3.581
75
Net profit
5.954
3.117
5.547
12.695
-16.021
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
2025
Total assets
29.882
32.076
38.448
52.976
36.757
Equity
28.124
31.241
36.789
49.484
33.463
Long-term debt
0
0
0
0
0
Short-term debt
1.758
835
1.660
3.492
3.294
Total debt
1.758
835
1.660
3.492
3.294
Financial ratios
5-year trend
EBITDA margin (of gross profit)
100.0%
This company
2021
2025
Equity ratio
91.0%
This company
38.2%
Market median
+138% vs market
2021
2025
Return on equity
-47.9%
This company
18.4%
Market median
-360% vs market
2021
2025
Net profit margin (of gross profit)
-16870.3%
This company
2021
2025
Asset turnover (of gross profit)
0.00×
This company
2021
2025
Debt / equity
0.10×
This company
0.62×
Market median
+84% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2024-06-01 – 2025-05-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2023-06-01 – 2024-05-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2022-06-01 – 2023-05-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2021-06-01 – 2022-05-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2020-06-01 – 2021-05-31
View
PDF
More on VELIN-PHARMA A/S
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
